A Kinase Inhibitor Screen Reveals Protein Kinase C-dependent Endocytic Recycling of ErbB2 in Breast Cancer Cells-Reference-Cited by-同舟云学术

A Kinase Inhibitor Screen Reveals Protein Kinase C-dependent Endocytic Recycling of ErbB2 in Breast Cancer Cells

Published:2014-10 Issue:44 Volume:289 Page:30443-30458
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Bailey Tameka A.,Luan Haitao,Tom Eric,Bielecki Timothy Alan,Mohapatra Bhopal,Ahmad Gulzar,George Manju,Kelly David L.,Natarajan Amarnath,Raja Srikumar M.,Band Vimla,Band Hamid

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference115 articles.

1. A census of amplified and overexpressed human cancer genes;Santarius;Nat. Rev. Cancer,2010

2. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3;Baselga;Nat. Rev. Cancer,2009

3. Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu;Xu;Proc. Natl. Acad. Sci. U.S.A,2002

4. ErbB2 degradation mediated by the co-chaperone protein CHIP;Zhou;J. Biol. Chem,2003

5. Development of small molecule Hsp90 inhibitors: utilizing both forward and reverse chemical genomics for drug identification;Neckers;Curr. Med. Chem,2003

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphorylation of Rab29 at Ser185 regulates its localization and role in the lysosomal stress response in concert with LRRK2;Journal of Cell Science;2023-07-15

2. Assembly and disassembly dynamics of nonmuscle myosin II control endosomal fission;Cell Reports;2023-02

3. EHD2 overexpression promotes tumorigenesis and metastasis in triple-negative breast cancer by regulating store-operated calcium entry;eLife;2023-01-10

4. Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer;Cancers;2022-11-03

5. PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer;Frontiers in Endocrinology;2022-10-18